You just read:

Janssen Research and Development, LLC: New Two-year Guselkumab Data Show Patients with Moderate to Severe Plaque Psoriasis Achieved Consistent Rates of Skin Clearance

News provided by

Janssen

Sep 16, 2017, 02:00 ET